|
Michael Zobel to head LANXESS subsidiary Saltigo
Personnel change at specialty chemicals company LANXESS: Michael Zobel (50), currently head of the High Performance Materials (HPM) business unit, will take over the management of LANXESS subsidiary Saltigo from Torsten Derr (50) on June 1, 2020.
|
ECHA smooths the path for Saltigo’s active ingredient
In January 2020, the Biocidal Products Committee of the European Chemicals Agency (ECHA) published its opinion regarding the approval of the active ingredient Icaridin.
|
A great deal of expertise – for a great deal
Saltigo at CPhI Worldwide 2018, Madrid, Spain, October 9 to 11, 2018, Stand 10B110
|
Keeping inertial forces under control
Saltigo GmbH, a wholly owned subsidiary of specialty chemicals company LANXESS based in Leverkusen, assigns safety a high priority, and not just during the production process.
|
LANXESS featured on Health Briefs TV show airing nationally
Segment featuring Saltidin® (Picaridin) from LANXESS’ Saltigo business unit has started airing in the U.S.
|
Safeguarding the future through investment
Saltigo GmbH, a wholly owned subsidiary of specialty chemicals company LANXESS, will be showcasing its range of contract and exclusive synthesis services at Chemspec Europe.
